Since the IGF-1/GH axis contributes to the preservation of skeletal muscle mass [72], its modulation by supplementation of these hormones has been hypothesized to treat sarcopenia in older adults [79], but there is still no robust evidence of beneficial effects [80]. The gene discussed is GH1; the disease is sarcopenia.